Hesperetin derivative-14 alleviates inflammation by activating PPAR-γ in mice with CCl4-induced acute liver injury and LPS-treated RAW264.7 cells. (15th May 2017) - Chen, Xin
Highlights: Anti-inflammatory effects of hesperetin derivative-14 in vivo and in vitro . Hesperetin derivative-14 activates PPAR-γ expression in mice with ALI and LPS-induced RAW264.7 cells. The expression of p-JAK1 and p-STAT1 is attenuated by up-regulating PPAR-γ. Abstract: Hesperetin is a flavanone glycoside compound naturally occurring in the fruit peel of Citrusaurantium L . ( Rutaceae ). Previous studies revealed that hesperetin possesses various pharmacological effects, including anti-inflammation, anti-tumor, anti-oxidant and neuroprotective properties. Hesperetin derivative-14 (HD-14) is a derivative of hesperetin improved in water solubility and bioavailability. In this study, we indicated that HD-14 (2 μM) significantly attenuated inflammation in LPS-treated RAW264.7 cells, besides, HD-14 (100 mg/kg) exhibited hepato-protective effects and anti-inflammatory effects on C57BL/6J mice with CCl4 -induced acute liver injury. In addition, it was demonstrated that HD-14 dramatically up-regulated the expression of PPAR-γ in vivo and in vitro. Interestingly, over-expression of PPAR-γ had anti-inflammatory effects on the expressions of TNF-α, IL-6, and IL-1β, whereas, knockdown of PPAR-γ with small interfering RNA had pro-inflammatory effects in LPS-treated RAW264.7 cells. Thus, our findings demonstrated that HD-14 alleviated inflammation by activating PPAR-γ expression at least in part. Further studies founded that HD-14 remarkably inhibited the expression of p-JAK1 and p-STAT1 through up-regulating PPAR-γ. Together, these results suggested that HD-14 served as an activator of PPAR-γ and the JAK1/STAT1 signaling pathway may be involved in the progress of inflammation. Collectively, HD-14 may be utilized as a potential anti-inflammation monomeric compound in the treatment of acute liver injury.